Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Ok thanks for clarifying where the additional $700k came from...so we cant say Q4 rev of $1.7M all we can say is $5.5M 2017 revs moving fwd which is a nice YOY increase on their $2.2M 2016 rev.

I'm gonna guess/speculate that with the final 2 strengths of FocalinXR launched in Q1 2018 that IPCI is now on track to book at least $6M minimum in 2018...and perhaps $8M as long as MNK can win some SeroquelXR contract bids as contracts from others begin to expire throughout this year.

And I base the above 2018 revenue guesstimates on the fact that I firmly believe IPCI should bank $5M revenue from FocalinXR alone now that the final 2 remaining strengths have been launched with the 5mg strength being a big seller.